This study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Jeffrey R. Curtis, MD, MS, MPH
Advertisement
Articles by Jeffrey R. Curtis, MD, MS, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
Real-World Semaglutide Use Linked to Lower Liver Stiffness, With Benefits Beyond Weight Loss
3
After 2 CRLs, FDA Approves Vusolimogene Oderparepvec With Nivolumab for Advanced Melanoma
4
Expert Q&A: Hannaford's Vaccine Program Growth Fueled by Routine Integration, Technician Immunizer Expansion
5